Leup-XL 22.5 mg Injection 1's belongs to the class of synthetic hormones used in the treatment of prostate cancer in men, endometriosis, and hormone-responsive breast cancer in women. Also, Leup-XL 22.5 mg Injection 1's is used to treat premature puberty in children. Prostate cancer is cancer of the prostate gland (a small gland under the bladder that produces semen) found only in men. The symptoms include difficulty in urination, pain, numbness, or sexual problems.

Leup-XL 22.5 mg Injection 1's contains Leuprorelin, a synthetic hormone that works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and estrogen in women. Thereby, Leup-XL 22.5 mg Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of the tumor or causing it to shrink.  

Use Leup-XL 22.5 mg Injection 1's as prescribed by your doctor. You are advised to take Leup-XL 22.5 mg Injection 1's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience pain, redness, swelling, or skin hardening at the injection site, muscle weakness, bone pain, inability to have an erection, breast tenderness, headache, vaginal dryness, changes in breast size, acne, or mood swings. Most of these side effects of Leup-XL 22.5 mg Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Leup-XL 22.5 mg Injection 1's or any other medicines, please tell your doctor. Leup-XL 22.5 mg Injection 1's is contraindicated in pregnant and breastfeeding women. It is advised to use effective contraceptive measures to avoid pregnancy while taking Leup-XL 22.5 mg Injection 1's as it may cause birth defects. Leup-XL 22.5 mg Injection 1's should be used with caution in children. You are recommended to avoid or limit consumption of alcohol with Leup-XL 22.5 mg Injection 1's as it may increase the risk of bone density loss. Drive only if you are alert as Leup-XL 22.5 mg Injection 1's may cause dizziness, drowsiness, or vision disturbances.

Leup-XL 22.5 mg Injection 1's contains Leuprorelin which works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and oestrogen in women. Thereby, Leup-XL 22.5 mg Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of the tumour or causing it to shrink.  Also, Leup-XL 22.5 mg Injection 1's is used to treat hormone-responsive breast cancer in pre and postmenopausal women. By reducing testosterone and oestrogen levels, Leup-XL 22.5 mg Injection 1's delays the onset of puberty in children.

If you are allergic to Leup-XL 22.5 mg Injection 1's or any other medicines, please tell your doctor. Leup-XL 22.5 mg Injection 1's is contraindicated in pregnant and breastfeeding women. It is advised to use effective non-hormonal contraceptives such as condoms to avoid pregnancy while taking Leup-XL 22.5 mg Injection 1's as it may cause birth defects. Leup-XL 22.5 mg Injection 1's should be used with caution in children. You are advised to quit smoking as it may increase the risk of prostate cancer. You are recommended to avoid or limit consumption of alcohol with Leup-XL 22.5 mg Injection 1's as it may increase the risk of bone density loss. Drive only if you are alert as Leup-XL 22.5 mg Injection 1's may cause dizziness, drowsiness or vision disturbances.